SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $11.43 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-31
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $11.43M, a 25.01% increase from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $9.14M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $11.43M 10-K · filed 2026-03-31 |
| 2024-12-31 | $9.14M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |